72 related articles for article (PubMed ID: 22967707)
1. Effect of cyclin [corrected] D1 (CCND1) gene polymorphism on tumor formation and behavior in patients with prolactinoma.
Cander S; Ertürk E; Karkucak M; Oz Gül O; Görükmez O; Yakut T; Unal OK; Ersoy C; Tuncel E; Imamoğlu S
Gene; 2012 Nov; 509(1):158-63. PubMed ID: 22967707
[TBL] [Abstract][Full Text] [Related]
2. Altered cyclin D1 genotype distribution in human sporadic pituitary adenomas.
Gazioglu NM; Erensoy N; Kadioglu P; Sayitoglu MA; Ersoy IH; Hatirnaz O; Kisacik B; Oz B; Sar M; Ozbek U; Ciplak N; Cagatay P
Med Sci Monit; 2007 Oct; 13(10):CR457-63. PubMed ID: 17901853
[TBL] [Abstract][Full Text] [Related]
3. Cyclin D1 (CCND1) genotype is associated with tumour grade in sporadic pituitary adenomas.
Simpson DJ; Fryer AA; Grossman AB; Wass JA; Pfeifer M; Kros JM; Clayton RN; Farrell WE
Carcinogenesis; 2001 Nov; 22(11):1801-7. PubMed ID: 11698342
[TBL] [Abstract][Full Text] [Related]
4. Lack of evidence for predictive and prognostic value of cyclin D1 gene polymorphism CCND1 G870A for oral squamous cell carcinoma.
Atac A; Riecke B; Assaf AT; Gröbe A; Friedrich RE; Heiland M; Izbicki JR; Kluwe L; Blessmann M
Anticancer Res; 2014 Jan; 34(1):235-8. PubMed ID: 24403468
[TBL] [Abstract][Full Text] [Related]
5. Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer.
Bedewy AM; Mostafa MH; Saad AA; El-Maghraby SM; Bedewy MM; Hilal AM; Kandil LS
J BUON; 2013; 18(1):227-38. PubMed ID: 23613410
[TBL] [Abstract][Full Text] [Related]
6. Does DRD2 polymorphism influence the clinical characteristics of prolactinoma?
Ilhan M; Kahraman OT; Turan S; Turgut S; Karaman O; Zeybek U; Shukurov S; Yaylim I; Tasan E
Ann Endocrinol (Paris); 2015 Oct; 76(5):614-9. PubMed ID: 26514951
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of transforming growth factor-beta receptor type II and Smad3 tumor suppressor genes in prolactinomas.
Ikeda H
Brain Tumor Pathol; 2006 Apr; 23(1):7-12. PubMed ID: 18095113
[TBL] [Abstract][Full Text] [Related]
8. Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers.
Grieu F; Malaney S; Ward R; Joseph D; Iacopetta B
Anticancer Res; 2003; 23(5b):4257-9. PubMed ID: 14666635
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in prolactin pituitary tumors: clinical, histological, and molecular data from a series of 94 patients with a long postoperative follow-up.
Raverot G; Wierinckx A; Dantony E; Auger C; Chapas G; Villeneuve L; Brue T; Figarella-Branger D; Roy P; Jouanneau E; Jan M; Lachuer J; Trouillas J;
J Clin Endocrinol Metab; 2010 Apr; 95(4):1708-16. PubMed ID: 20164287
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 polymorphism and the risk of endometrial cancer.
Kang S; Kim JW; Park NH; Song YS; Kang SB; Lee HP
Gynecol Oncol; 2005 May; 97(2):431-5. PubMed ID: 15863141
[TBL] [Abstract][Full Text] [Related]
11. [Cyclin D1 gene G870A polymorphism and susceptibility to nasopharyngeal carcinoma].
Sui J; Gao W; Li XJ; Ma J; Ren YX; Song X; Xiao CJ; Tang WR
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Mar; 44(3):227-31. PubMed ID: 19558863
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer and cyclin D1 gene polymorphism in Turkish women.
Yaylim-Eraltan I; Ergen A; Görmüs U; Arikan S; Küçücük S; Sahin O; Yigit N; Yildiz Y; Isbir T
In Vivo; 2009; 23(5):767-72. PubMed ID: 19779113
[TBL] [Abstract][Full Text] [Related]
13. The Role of
Turgut S; Ilhan M; Turan S; Karaman O; Yaylim I; Kucukhuseyin O; Tasan E
In Vivo; 2017; 31(3):357-363. PubMed ID: 28438863
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck.
Matthias C; Branigan K; Jahnke V; Leder K; Haas J; Heighway J; Jones PW; Strange RC; Fryer AA; Hoban PR
Clin Cancer Res; 1998 Oct; 4(10):2411-8. PubMed ID: 9796972
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 G870A polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: case-control study.
Akkiz H; Bayram S; Bekar A; Akgöllü E; Ozdil B
Cancer Epidemiol; 2010 Jun; 34(3):298-302. PubMed ID: 20347627
[TBL] [Abstract][Full Text] [Related]
16. [Correlation analysis of G870A CCND1 gene polymorphism with digestive system tumors].
Yang SM; Shi YL
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Nov; 36(11):1589-1592. PubMed ID: 27881356
[TBL] [Abstract][Full Text] [Related]
17. The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population.
Yaylim-Eraltan I; Arikan S; Yildiz Y; Cacina C; Ergen HA; Tuna G; Görmüs U; Zeybek U; Isbir T
Anticancer Res; 2010 Jul; 30(7):2875-80. PubMed ID: 20683026
[TBL] [Abstract][Full Text] [Related]
18. Association of cyclin D1 genotypes with nasopharyngeal carcinoma risk.
Shih LC; Tsai CW; Tsai MH; Tsou YA; Chang WS; Li FJ; Lee MH; Bau DT
Anticancer Res; 2012 Mar; 32(3):1093-8. PubMed ID: 22399638
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 polymorphism (G870A) and risk for esophageal adenocarcinoma.
Casson AG; Zheng Z; Evans SC; Geldenhuys L; van Zanten SV; Veugelers PJ; Porter GA; Guernsey DL
Cancer; 2005 Aug; 104(4):730-9. PubMed ID: 15971196
[TBL] [Abstract][Full Text] [Related]
20. Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1.
Yu CP; Yu JC; Sun CA; Tzao C; Ho JY; Yen AM
Breast Cancer Res Treat; 2008 Jan; 107(1):95-102. PubMed ID: 18043898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
